medigraphic.com
Instituto Nacional de Salud Pública

2016, Number 4

<< Back Next >>

salud publica mex 2016; 58 (4)

Bacterial resistance from urine cultures at an oncological center: follow-up to 10 years

Velázquez-Acosta C, Cornejo-Juárez P, Volkow-Fernández P

Language: Spanish
References: 27
Page: 446-452
PDF size: 259.56 Kb.


ABSTRACT

Objective. To describe the incidence and patterns of bacterial resistance in urine samples from a tertiary care oncology hospital in Mexico, from 2004 to 2013. Materials and methods. We included the strains obtained from urine cultures, describing separately multidrug-resistant (MDR) bacteria. We analyzed the susceptibility to different antibiotics. Results. 51 202 urine cultures were processed during the study; 14 480 (28.3%) cultures were positive. In 11 427 samples Gram negative (79%) were isolated, 2 080 Gram positive (14.4%), and 973 yeasts (6.6%). Escherichia coli was the most frequent bacteria identified (56.1%); 24% of the community strains and 65.7% of the nosocomial were extended-spectrum beta-lactamase producers (ESBL). Klebsiella pneumoniae was isolated in 705 samples (4.8%); 115 were ESBL (16%), 13.1% from community and 29.8% from nosocomial source. Pseudomonas aeruginosa was identified in 593 cultures (4.1%): 9% from community and 51% nosocomial. Conclusions. MDR bacteria were more frequent in nosocomial isolates. It should be a priority to intensify the rational use of antimicrobials in the community and antibiotic stewardship in the hospital.


REFERENCES

  1. Secretaría de Salud. Sistema Nacional de Vigilancia Epidemiológica. Panorama epidemiológico de las infecciones de vías urinarias en México 2003-2008. Epidemiología 2009;51-52:1-4,1-3.

  2. Barford JM, Anson K, Hu Y, Coates AR. A model of catheter-associated urinary tract infection initiated by bacterial contamination of the catheter tip. BJU Int 2008;102:67-74. http://doi.org/fd7xv7

  3. Aguilar-Duran S, Horcajada JP, Sorlí L, Montero M, Salvadó M, Grau S, et al. Community-onset healthcare-related urinary tract infections: comparison with community and hospital-acquired urinary tract infections. J Infect 2012;64:478-483. http://doi.org/fxswmd

  4. Arredondo-García JL, Soriano-Becerril D, Solórzano-Santos F, Arbo- Sosa A, Coria-Jiménez VR. Etiología y tratamiento de infecciones de vías urinarias (UTIS) en niños. Rev Enferm Infecc Pediatr 2006;19:100-106.

  5. Norma Oficial Mexicana NOM-045-SSA2-2005, Para la vigilancia epidemiológica, prevención y control de las infecciones nosocomiales. Secretaría de Salud. México: DOF, 20 de noviembre de 2009.

  6. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM, Infectious Diseases Society of America, American Society of Nephrology, American Geriatric Society. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005;40:643-654. http://doi.org/bk26dj

  7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 33th Informational supplement, Vol. 32, No. 3. Wayne, PA: CLSI, 2012.

  8. Cornejo-Juárez P, Velásquez-Acosta C, Sandoval S, Gordillo P, Volkow- Fernández P. Antimicrobial resistance patterns of isolates from urine cultures at an oncological center. Salud Publica Mex 2007;49:330-336. http://doi.org/dn9fnw

  9. Chenowth CE, Saint S. Urinary tract infections. Infect Dis Clin North Am 2011;25:103-115. http://doi.org/b6gtqc

  10. Czaja CA, Scholes D, Hooton TM, Stamm WE. Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis 2007;45:273-280. http://doi.org/cdhj8r

  11. Huoi C, Vanhems P, Nicolle MC, Michallet M, Bénet T. Incidence of hospital-acquired pneumonia, bacteraemia and urinary tract infections in patients with haematological malignancies, 2004-2010: a surveillance-based study. PLoS One 2013;8(3):e58121. http://doi.org/bd5x

  12. Foxman B, Barlow R, D’Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000;10:509-515. http://doi.org/dg6mpc

  13. Junquera S, Loza E, Baquero F. Changes in the antimicrobial susceptibility of Escherichia coli isolates from nosocomial versus community- acquired urinary tract infections. Enferm Infecc Microbio Clin 2005;23:197-201. http://doi.org/cbq3cf

  14. Andreu-Domingo A, Cacho J, Coira-Nieto A, Lepe-Jiménez JA. Diagnóstico microbiológico de las infecciones del tracto urinario. En: Procedimientos en Recomendaciones de la Sociedad Española de Enfermedades Infecciosas y microbiología clínica (14va ed). España: EIMC, 2010:1-14.

  15. Cornejo-Juárez P, Pérez-Jiménez C, Silva-Sánchez J, Velázquez-Acosta C, González-Lara F, Reyna-Flores F, et al. Molecular analysis and risk factors for Escherichia coli producing extended-spectrum β-lactamase bloodstream infection in hematological malignancies. PLoS One 2012;7:e35780. http://doi.org/bd5z

  16. Montes CV, Vilar-Compte D, Velazquez C, Golzarri MF, Cornejo-Juárez P, Larson EL. Risk factors for extended spectrum β-lactamase-producing Escherichia coli versus susceptible E. coli in surgical site infections among cancer patients in Mexico. Surg Infect (Larchmt) 2014;15:627-634. http:// doi.org/bd52

  17. Ahmed NH, Raghuraman K, Baruah FK, Grover RK. Antibiotic Resistance Pattern of Uropathogens: An experience from North Indian cancer patient. J Glob Infect Dis 2015;7:113-115. http://doi.org/bd53

  18. Salles MJ, Zurita J, Mejía C, Villegas MV; Latin America Working Group on Bacterial Resistance. Resistant gram-negative infections in the outpatient setting in Latin America. Epidemiol Infect 2013;141:2459-2472. http:// doi.org/bd54

  19. Gales AC, Castanheira M, Jones RN, Sader HS. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). Diagn Microbiol Infect Dis 2012;73:354-360. http://doi.org/bd55

  20. Guh AY, Bulens SN, Mu Y, Jacob JT, Reno J, Scott J, et al. Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012- 2013. JAMA 2015;314(14):1479-1487. http://doi.org/bd56

  21. Briongos-Figuero LS, Gómez-Traveso T, Bachiller-Luque P, Domínguez- Gil, González M, Gómez-Nieto A, et al. Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum Beta-lactamase (ESBL)-producing enterobacteria. Int J Clin Pract 2012;66:891-896. http://doi.org/bd57

  22. Pigrau C, Rodríguez D. Infecciones asociadas a dispositivos para drenaje de las vías urinarias. Enf Infecc Microbiol Clin 2008;26:299-310. http:// doi.org/ddvgk2

  23. Hooton TM. Uncomplicated urinary tract infection. N Engl J Med 2012;366:1028-1037. http://doi.org/63g

  24. Nicolle LE. Urinary catheter-associated infections. Infect Dis Clin North Am 2012;26:13-27. http://doi.org/bd58

  25. Wang QY, Li RH, Shang XH. Urinary tract infection caused by Enterococcus isolates: aetiology and antimicrobial resistance patterns. J Chemother 2015;27:117-119. http://doi.org/bd59

  26. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK; National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities. NHSN annual update: antimicrobialresistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29:996-1011. http://doi.org/cnbqb3

  27. Kamboj M, Sepkowits KA. Nosocomial infections in patients with cancer. Lancet Oncol 2009;10:589-597. http://doi.org/bgr5c5




2020     |     www.medigraphic.com